MedTrace Logo

Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.

NCT03960242 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2022-12-21

No results posted yet for this study

Summary

The objective of this study is the longitudinal prospective clinical evaluation in patients with motor predominant PD; it will assess the individual disease progression (change) of the clinical and imaging parameters measured at 6-month interval over a minimum of 12 months.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • BrainEver

    lead INDUSTRY

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-14
Primary Completion
2021-04-18
Completion
2021-04-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03960242 on ClinicalTrials.gov